UnknownNot applicableNCT02854579

Neural Progenitor Cell and Paracrine Factors to Treat Hypoxic Ischemic Encephalopathy

Studying Neonatal hypoxic and ischemic brain injury

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Navy General Hospital, Beijing
Principal Investigator
Zuo Luan, MD
Navy General Hosiptal
Intervention
neural progenitor cell(biological)
Enrollment
120 enrolled
Eligibility
All sexes
Timeline
20132017

Study locations (2)

Collaborators

Bethune International Peace Hospital · Daping Hospital and the Research Institute of Surgery of the Third Military Medical University · Hunan Children's Hospital · Shangluo Central Hospital · 252 Military Hospital

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT02854579 on ClinicalTrials.gov

Other trials for Neonatal hypoxic and ischemic brain injury

Additional recruiting or active studies for the same condition.

See all trials for Neonatal hypoxic and ischemic brain injury

← Back to all trials